1. Ginkgo-tree dermatitis, stomatitis, and proctitis . JAMA 1975;231:1162-1163. PubMed
, .2.
. The Herb Quarterly . 1990 Spring:26.3. Ginkgo—myth and reality [in German]. Schweiz Rundsch Med Prax . 1995;84:1-6.
.4. Ginkgo biloba L . Fitoterapia . 1998;LXIX:195-244.
, , , .5. Concentration of Ginkgolides and bilobalide in Ginkgo biloba leaves in relation to the time of year . Planta Med . 1992;58:413-416. PubMed
, .6. Gingko biloba . In:
, et al, eds. Adverse Effects of Herbal Drugs. New York, NY: Springer–Verlag; 1997:51-66.7.
, , . Herbal Medicines: A Guide for Health-Care Professionals . London, England: Pharmaceutical Press; 1996:138-140.8. HPLC separation and quantitative determination of biflavones in leaves from Ginkgo biloba . J Med Plant Res . 1983;49:204-207. PubMed
, , .9. Chemistry and biology of alkylphenols from Ginkgo biloba L . Pharmazie . 1997;52:735-738. PubMed
, .10. Biological standardization of Ginkgo extracts [in German]. Planta Med . 1993;59:155-160. PubMed
, , .11. Identification of flavonoid metabolites after oral administration to rats of a Ginkgo biloba extract . J Chromatogr B Biomed Appl . 1995;673:75-80. PubMed
, , , , .12. Comparative pharmacokinetics and bioavailability of flavonoid glycosides of Ginkgo biloba after a single oral administration of three formulations to healthy volunteers . Mater Med Pol . 1995;27:141-146. PubMed
, , , et al.13. Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761) [in French]. Therapie . 1995;50:137-144. PubMed
, , , et al.14. The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet- activating factor (PAF) . J Ethnopharmacol . 1996;50:131-139. PubMed
, , .15. Extract of Ginkgo biloba induces phase 2 genes through Keap1-Nrf2-ARE signaling pathway . Life Sciences . 2007; In Press, Accepted Manuscript.
, , , et al.16. Decreased cerebral 5-HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761) . J Pharm Pharmacol . 1994;46:316-318. PubMed
, , .17. Ginkgo biloba extract protects brain neurons against oxidative stress induced by hydrogen peroxide . Brain Res . 1996;712:349-352. PubMed
, , , , .18. Ginkgo biloba extract (EGb 761): inhibitory effect on nitric oxide production in the macrophage cell line RAW 264. 7 . Biochem Pharmacol . 1997;53:897-903. PubMed
, , , .19. Lipoperoxidation induced by hydrogen peroxide in human erythrocyte membranes. 2. Comparison of the antioxidant effect of Ginkgo biloba extract (EGb 761) with those of water-soluble and lipid-soluble antioxidants . J Int Med Res . 1995;23:9-18. PubMed
, .20. Comparative antilipoperoxidant, antinecrotic and scavenging properties of terpenes and biflavones from Ginkgo and some flavonoids . Planta Med . 1995;61:126-129. PubMed
, , , .21. Peroxyl radical scavenging activity of Ginkgo biloba extract EGb 761 . Biochem Pharmacol . 1995;49:1649-1655. PubMed
, , , .22. Ginkgo biloba extract (EGb 761) protects human low density lipoproteins against oxidative modification mediated by copper . Biochem Biophys Res Commun . 1995;212:360-366. PubMed
, , .23. Clastogenic factors in the plasma of Chernobyl accident recovery workers: anticlastogenic effect of Ginkgo biloba extract . Radiat Res . 1995;144:198-205. PubMed
, , , et al.24. An adjunctive preventive treatment for cancer: ultraviolet light and Ginkgo biloba , together with other antioxidants, are a safe and powerful, but largely ignored, treatment option for the prevention of cancer . Med Hypotheses . 2006;66:1152-1156. PubMed
, .25. A preliminary investigation of Tanakan in the treatment of hypertensive arteriosclerosis and stroke in rats . Chin Med J [in English]. 2000;113:425-428. PubMed
, , , , .26. The effect of Ginkgo biloba (EGb 761) on arteriosclerotic nanoplaque formation and size in a long-term clinical trial . Desalination . 2006;191:426-431.
, , , et al.27. Common gene targets of Ginkgo biloba extract (EGb 761) in human tumor cells: relation to cell growth . Cell Mol Biol . 2002;48:655-662.
, , , , .28. Cancer-related overexpression of the peripheral-type benzodiazepine receptor and cytostatic anticancer effects of Ginkgo biloba extract (EGb 761) . Anticancer Res . 2006;26(1A):9-22. PubMed
, , , et al.29. Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells . Oral Oncol . 2005;41:383-389.
, , , , , .30. Protective effects of Ginkgo biloba extract on gastric mucosa . Acta Pharmacol Sin . 2000;21:1153-1156. PubMed
, , .31. Protective effects of Ginkgo biloba extract on the ethanol-induced gastric ulcer in rats . World J Gastroenterol . 2005;11:3746-3750. PubMed
, , , et al.32. Therapeutic mechanism of Ginkgo biloba exocarp polysaccharides on gastric cancer . World J Gastroenterol . 2003;9:2424-2427. PubMed
, , , et al.33. Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer . Phytother Res . 2001;15:34-38. PubMed
, , , , .34. Ginkgo biloba and ovarian cancer prevention: Epidemiological and biological evidence . Cancer Lett . 2006 Dec 26; [Epub ahead of print].
, , , et al.35. Preliminary results in the modifications of cerebral blood flow using xenon-133 during administration of Ginkgo biloba [in Italian]. Minerva Med . 1973;64(suppl 79):4166-4173. PubMed
, , .36. EEG profile of three different extractions of Ginkgo biloba . Neuropsychobiology . 1993;27:40-45. PubMed
.37. Ginkgo biloba for cerebral insufficiency . Br J Clin Pharmacol . 1992;34:352-358. PubMed
, .38. Evidence for a therapeutic effect of Ginkgo biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age [in German]. Arzneimittelforschung . 1994;44:1005-1013. PubMed
.39. Involvement of Ca2+ , CaMK II and PKA in EGb 761-induced insulin secretion in INS-1 cells . J Ethnopharmacol . 2007;110:49-55.
, , , et al.40. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761) and bilobalide on liver and muscle glycogen contents in the non-insulin-dependent diabetic rat . Drug Development Research . 1997;40:68-74.
, , , .41. Effects of the flavonoid fraction from Ginkgo biloba extract on the postprandial blood glucose elevation in rats [in Japanese]. Yakugaku Zasshi . 2004;124:605-611.
, , , .42. Ginkgo biloba extract protects rat kidney from diabetic and hypoxic damage . Phytomedicine . 2006 Jun 15; [Epub ahead of print].
, , , , , .43. Protective effects of Ginkgo biloba extract on cultured rat cardiomyocytes damaged by H2 O2 . Zhongguo Yao Li Xue Bao . 1999;20:635-638. PubMed
, , .44. Ultrastructural, immunohistochemical and biochemical investigations of the rat liver exposed to experimental diabetes and acute hypoxia with and without application of Ginkgo extract . Exp Toxicol Pathol . 2004;55:331-345.
, , , et al.45. The effect of 3-month ingestion of Ginkgo biloba extract on pancreatic beta-cell function in response to glucose loading in normal glucose tolerant individuals . J Clin Pharmacol . 2000;40:647-654.
.46. The effect of 3-month ingestion of Ginkgo biloba extract (EGb 761) on pancreatic beta-cell function in response to glucose loading in individuals with non-insulin-dependent diabetes mellitus . J Clin Pharmacol . 2001;41:600-611. PubMed
.47. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjectsa double blind placebo-controlled, crossover study . Clin Nutr . 2006;25:606-616. PubMed
, , , .48. Short-term ingestion of Ginkgo biloba extract does not alter whole body insulin sensitivity in non-diabetic, pre-diabetic or type 2 diabetic subjectsa randomized double-blind placebo-controlled crossover study . Clin Nutr . 2006;25:123-134. PubMed
, , , , , .49. Ginkgo biloba extract improves spatial memory in rats mainly but not exclusively via a histaminergic mechanism . Brain Res . 2007;1129:161-165.
, , , .50. Memory effects of standardized extracts of Panax ginseng (G115), Ginkgo biloba (GK 501) and their combination Gincosan (PHL-00701) . Planta Med . 1993;59:106-114. PubMed
, , , et al.51. Demonstration of the “anti-stress” activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task . Gen Pharmacol . 1994;25:1009-1016. PubMed
, , , .52. Effect of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects . Clin Ther . 1993;15:549-558. PubMed
, , , , , .53. Cognitive psychophysiology in nootropic drug research: effects of Ginkgo biloba on event-related potentials (P300) in age-associated memory impairment . Pharmacopsychiatry . 1995;28:134-142. PubMed
, , , , .54. The clinical application of Ginkgo biloba in dementia syndromes (restoration of brain performance in vascular or degenerative CNS disease) [in German]. Pharm Unserer Zeit . 1992;21:266-275. PubMed
.55. Natural substances in psychiatry ( Ginkgo biloba in dementia) . Psychopharmacol Bull . 1995;31:147-158. PubMed
, .56. Therapy approaches in cerebral cognitive deficits—neuropsychiatric aspects [in German]. Wien Med Wochenschr . 1996;146:546-548. PubMed
.57. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets . Eur J Pharmacol . 2006;545:51-64.
.58. The Ginkgo Evaluation of Memory (GEM) study: design and baseline data of a randomized trial of Ginkgo biloba extract in prevention of dementia . Contemp Clin Trials . 2006;27:238-253. PubMed
, , , et al; GEMS Investigators.59. Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience . Contemp Clin Trials . 2006;27:541-553. PubMed
, , , et al; GEM Study Investigators.60. The GuidAge study: Methodological issues. A 5-year double-blind randomized trial of the efficacy of EGb 761(R) for prevention of Alzheimer disease in patients over 70 with a memory complaint . Neurology . 2006;67(9 Suppl 3):S6-S11. PubMed
, , , , .61. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type of multi-infarct dementia . Pharmacopsychiatry . 1996;29:47-56. PubMed
, , , , .62. Effectiveness of brief infusions with Ginkgo biloba Special Extract EGb 761 in dementia of the vascular and Alzheimer type [in German]. Z Gerontol Geriatr . 1996;29:302-309.
, , .63. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group . JAMA . 1997;278:1327-1332. PubMed
, , , , , .64. Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer's disease . Neuropsychobiology . 2002;45:19-26. PubMed
, , , , , .65. Association of Alzheimer's disease onset with Ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study . J Gerontol A Biol Sci Med Sci . 2003;58:372-377. PubMed
, , , et al.66. Ginkgo biloba compared with cholinesterase inhibitors in the treatment of dementia: a review based on meta-analyses by the cochrane collaboration . Dement Geriatr Cogn Disord . 2004;18:217-226. PubMed
, .67. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study . Eur J Neurol . 2006;13:981-985. PubMed
, , , .68. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider . Phytomedicine . 2003;10(suppl 4):74-79. PubMed
.69. PubMed
, et al. A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J Clin Psychiatry . 2001;62:878-883.70. The effect of extract of Ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia . Psychiatry Clin Neurosci . 2005;59:652-656. PubMed
, , , , .71. Extract of Ginkgo biloba added to haloperidol was effective for positive symptoms in refractory schizophrenia . Evid Based Ment Health . 2002;5:90. PubMed
.72. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial . Psychopharmacology (Berl). 2006;188:12-17.
, , , .73. Ginkgo biloba extract in peripheral arterial diseases. Meta-analysis of controlled clinical studies . Arzneimittelforschung . 1992;42:428-436. PubMed
.74. Effects of natural antioxidant Ginkgo biloba extract (EGB 761) on myocardial ischemia-reperfusion injury . Free Radic Biol Med . 1994;16:789-794. PubMed
, , , , .75. Efficiency of Ginkgo biloba extract (EGb 761) in antioxidant protection against myocardial ischemia and reperfusion injury . Biochem Mol Biol Int . 1995;35:125-134. PubMed
, .76. Experimental thrombosis model induced by lase beam. Application of aspirin and an extract of Ginkgo biloba : EGb 761 . Thromb Res . 1996;82:453-458. PubMed
, , , et al.77. Treatment of angiodystrophic skin diseases with Ginkgo biloba [in Italian]. Minerva Med . 1973;64(suppl 79):198-200.
, .78. Hemorheologic effects of Ginkgo biloba extract EGb 761. Dose-dependent effect of EGb 761 on microcirculation and visoelasticity of blood [in German]. Fortschr Med . 1993;111:170-172. PubMed
, , , , .79. 6-month double-blind randomised clinical trial of Ginkgo biloba extract versus placebo in two parallel groups in patients suffering from peripheral arterial insufficiency . Arzneimittelforschung . 1984;34:716-720. PubMed
.80. Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication [in German]. Vasa . 1996;25:265-274. PubMed
, , .81. The effect of Ginkgo biloba extract in patients with intermittent claudication [in Danish]. Ugeskr Laeger . 1996;158:3928-3931. PubMed
, , , , .82. Ginkgo biloba in treatment of intermittent claudication. A systemic research based on controlled studies in the literature [in German]. Fortschr Med . 1996;114:85-87. PubMed
.83. Clinical results in therapy of peripheral vascular diseases with Ginkgo biloba [in Italian]. Minerva Med . 1973;64(suppl 79):4187-4193. PubMed
.84. Antidepressant-induced sexual dysfunction and Ginkgo biloba . Am J Psychiatry . 2000;157:836-837. PubMed
, , , .85. Dietary supplements for female sexual dysfunction . Am J Health-Syst Pharm . 2005;62:577-580.
, .86. Ginkgo Biloba relieves sexual dysfunction due to antidepressant drugs . European Neuropsychopharmacology . 1999;9(suppl 5):253-254.
.87. Triple-blind, placebo-controlled trial of Ginkgo biloba in sexual dysfunction due to antidepressant drugs . Hum Psychopharmacol . 2004;19:545-548. PubMed
.88. Extracts of Ginkgo biloba leaves inhibit monoamine oxidase . Life Sci . 1996;58:1315-1321. PubMed
, , .89. Identification of kaempferol as a monoamine oxidase inhibitor and potential neuroprotectant in extracts of Ginkgo biloba leaves . J Pharm Pharmacol . 2000;52:451-459. PubMed
, , , et al.90. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by Ginkgo biloba extract EGb 761 and isolated ginkgolides . Endocrinology . 1996;137:5707-5718. PubMed
, , , , .91. Anxiolytic-like effect of combined extracts of Zingiber officianle and Ginkgo biloba in the elevated plus-maze . Pharmacol Biochem Behav . 1996;53:271-275. PubMed
, , , et al.92. Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl betacarboline-3-carboxylate on social behavior of the rat . Pharmacol Biochem Behav . 1997;56:333-339. PubMed
, , , .93. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: A randomized, double-blind, placebo-controlled trial . J Psychiatr Res . 2006; [Epub ahead of print].
, , , .94. Ginkgo biloba extract for the treatment of tinnitus . Audiology . 1994;33:85-92. PubMed
, , .95. Attenuation of salicylate-induced tinnitus by Ginkgo biloba extract in rats . Audiol Neurootol . 1997;2:197-212. PubMed
, , , , .96. The medicinal herb ginkgo reverses thermal hyperalgesia in a model of post-surgical pain . Eur J Pain . 2006;10(suppl 1):S84.
, .97. Preliminary study on early fibrosis of chronic hepatitis B treated with Ginkgo biloba Composita [in Chinese]. Zhongguo Zhong Xi Yi Jie He Za Zhi . 1995;15:593-595. PubMed
, , .98. Ginkgo biloba inhibits bleomycin-induced lung fibrosis in rats . Pharmacol Res . 2006;53:310-316. PubMed
, , , et al.99. Activity of bilobalide, a sesquiterpene from Ginkgo biloba , on Pneumoncystis carinii . Antimicrob Agents Chemother . 1993;37:1492-1496. PubMed
, , , , , .100. The effect of Ginkgo biloba extract on EEG spectra in experimental diabetes: no relation to lipid peroxidation . Int J Neurosci . 1994;76:259-266. PubMed
, , , .101. The correlation of cytophotometrically and biochemically measured enzyme activities: changes in the myocardium of diabetic and hypoxic diabetic rats, with and without Ginkgo biloba extract treatment . Acta Histochem . 1997;99:291-299. PubMed
, , , .102. Anti-influenza virus activity of biflavonoids . Bioorg Med Chem Lett . 2007;17:772-775. PubMed
, , , et al.103. Limitation of the deterioration of lipid parameters by a standardized garlic-ginkgo combination product. A multicenter placebo-controlled double-blind study . Arzneimittelforschung . 1993;43:978-981. PubMed
, .104. The Ginkgo biloba extract (EGb 761) provides a neuroprotective effect on retinal ganglion cells in a rat model of chronic glaucoma . Curr Eye Res . 2004;28:153-157. PubMed
, , , , , .105. Complementary therapy for the treatment of glaucoma: a perspective . Ophthalmol Clin North Am . 2005;18:597-609. PubMed
.106. Value of standardized Ginkgo biloba extract (EGb 761) in the management of congestive symptoms of premenstrual syndrome [in French]. Ref Fr Gynecol Obstet . 1993;88:447-457. PubMed
, .107. Antiestrogenic activities of Ginkgo biloba extracts . J Steroid Biochem Mol Biol . 2006;100:167-176.
, .108. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial . Explore (NY) . 2006;2:19-24.
, , , , , .109. EGb 761: Ginkgo biloba extract, Ginkor . Drugs R D . 2003;4:188-193.
110. Ginkgo biloba for acute ischaemic stroke . Cochrane Database Syst Rev . 2005;(4):CD003691. PubMed
, , , , .111. Bilobalide prevents ischemia-induced edema formation in vitro and in vivo . Neuroscience . 2007;144:217-222. PubMed
, , , , .112. Role of GABAergic antagonism in the neuroprotective effects of bilobalide . Brain Res . 2007;1128:70-78.
, , , et al.113. A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats . Neurosci Lett . 2006;398:28-33.
, , , et al.114. Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitis . Pharmacol Res . 2006;53:324-330. PubMed
, , , .115. Demonstration of the efficacy of Ginkgo biloba special extract EGb 761 on intermittent claudicationa placebo-controlled, double-blind multicenter trial . Vasa . 1998;27:106-110. PubMed
, , .116. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia . Phytomed . 1997;4:3-13. PubMed
, , , , .117. Cholinesterase inhibitor and ginkgo extracts in therapy of dementia. A comparison of effectiveness based on controlled studies [in German]. Fortschr Med . 1999;117:48-49. PubMed
.118. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo-controlled study on different levels of investigation . Human Psychopharmacol . 1994;9:215-222.
.119. The effect of Ginkgo biloba on neurophysiological and psychometric measurement results in patients with psychotic organic brain syndrome. A double-blind study against placebo [in German]. Arzneimittelforschung . 1989;39:918-922. PubMed
.120. Therapeutic trial in acute cochlear deafness. A comparative study of Ginkgo biloba extract and nicergoline [in French]. Presse Med . 1986;15:1559-1561. PubMed
.121. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group . JAMA . 1997;278:1327-1332. PubMed
, , , , , .122. Safety and efficacy of ginkgo ( Ginkgo biloba ) during pregnancy and lactation . Can J Clin Pharmacol . 2006;13:e277-284. PubMed
, , , .123. Intra-uterine growth retardation after prenatal administration of Ginkgo biloba to rats . Reprod Toxicol . 2007 Jan 14; [Epub ahead of print].
, , , , .124. Inhibition of human cytochromes P450 by components of Ginkgo biloba . J Pharm Pharmacol . 2004;56:1039-1044. PubMed
, , , et al.125. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1 . Toxicol Appl Pharmacol . 2006;213:18-26.
, , .126. Herb-drug interactions: a literature review . Drugs . 2005;65:1239-1282. PubMed
, , , et al.127. Evidence-based drug--herbal interactions . Life Sci . 2006;78:2146-2157. PubMed
, , .128. Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion . Neurology . 1996;46:1175-1176.
, .129. Ginkgo biloba . Neurology . 1997;48:1137. PubMed
.130. Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in stable, long-term warfarin treated outpatients. A randomized, double blind, placebo-crossover trial . Thromb Haemost . 2002;87:1075-1076. PubMed
, , .131. Fatal seizures due to potential herb-drug interactions with Ginkgo biloba . J Anal Toxicol . 2005;29:755-758. PubMed
, .132. Ginkgo biloba extract: As a novel agent in prevention of valproic acid hepatotoxicity . Medical Hypotheses . 2007;68:918-919. PubMed
, .133. Pentylenetetrazol-induced kindling seizure attenuated by Ginkgo biloba extract (EGb 761) in mice . Prog Neuropsychopharmacol Biol Psychiatry . 2006;30:1504-1510. PubMed
, , , .134. An open trial of nifedipine-herb interactions: nifedipine with St. John's wort, ginseng or Ginkgo biloba . Clin Pharmacol Ther . 2001;69:P86.
, et al.135. Induction of propranolol metabolism by Ginkgo biloba extract EGb 761 in rats . Curr Drug Metab . 2006;7:577-587. PubMed
, , , et al.136. Spontaneous hyphema associated with ingestion of Ginkgo biloba extract . N Engl J Med . 1997;336:1108. PubMed
, .137. Effect of ginkgolide mixture (BN 52063) in antagonizing skin and platelet responses to platelet activating factor in man . Lancet . 1987;1:248-250. PubMed
, , , , , .138. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers . J Clin Psychopharmacol . 2003;23:576-581. PubMed
, , , , .139. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers . J Clin Pharmacol . 2006;46:1290-1298. PubMed
, , , et al.140. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats . Food Chem Toxicol . 2006;44:1572-1578. PubMed
, , , , , .141. Impact of ginkgo biloba on the pharmacokinetics of digoxin . Am J Ther . 2003;10:247-251. PubMed
, , , , , .142. Fatal intracerebral mass bleeding associated with Ginkgo biloba and ibuprofen . Atherosclerosis . 2003;167:367. PubMed
, , .143. Prediction and mechanism of herb-drug interaction: effect of Ginkgo biloba on omeprazole in Chinese subjects . Clin Pharmacol Ther . 2003;73:P94.
, et al.144. Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury . Brain Inj . 2002;16:359-367. PubMed
, .145. Coma in a patient with Alzheimer's disease taking low dose trazodone and Ginkgo biloba . J Neurol Neurosurg Psychiatry . 2000;68:679-680. PubMed
, , , , .146. Ginkgo biloba -induced frequent ventricular arrhythmia . Ital Heart J . 2002;3:689-691. PubMed
, , , .147. Acute generalised exanthematous pustulosis induced by the herbal remedy Ginkgo biloba . Med J Aust . 2006;184:583-584. PubMed
.148. Partial purification and analysis of allergenicity, immunogenicity of Ginkgo biloba L. pollen [in Chinese]. Hua Xi Yi Ka Da Xue Xue Bao . 1992;23:429-432. PubMed
, , .149. Spontaneous bleeding associated with Ginkgo biloba : a case report and systematic review of the literature: a case report and systematic review of the literature . J Gen Intern Med . 2005;20:657-661. PubMed
, , , .150. Spontaneous hyphema caused by Ginkgo biloba extract . J Fr Ophtalmol . 2002;25:731-732. PubMed
, , , , .151. Ginkgo biloba precipitating epileptic seizures . Age Ageing . 2001;30:523-525. PubMed
.152. Studies on the constituents of edible and medicinal plants. ΙV. Determination of 4-O-methylpyridoxine in serum of the patient with gin-nan food poisoning [in Japanese]. Yakugaku Zasshi . 1993;113:596-599. PubMed
, , , , .153. Ginkgo nut intoxication in a 2-year-old male . Pediatr Neurol . 2006;35:275-276.
, , , , .154. Generalized convulsions after consuming a large amount of gingko nuts . Epilepsia . 2001;42:280-281. PubMed
, , , .155. Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers . J Clin Pharmacol . 2006;46:1290-1298. PubMed
, , , et al.